By
Drug Target Review2023-11-09T16:00:22
Six types of inflammation with various cell types and disease pathways identified may provide better treatment of rheumatoid arthritis.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-01-26T13:22:42
Sponsored by bit.bio
2023-07-04T10:05:58
Sponsored by Revvity
2026-05-25T07:00:00
Contributor Professor Neville Sanjana
2025-05-14T14:30:00
Sponsored by Abzena
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-07-03T10:28:23
Sponsored by Merck
Site powered by Webvision Cloud